Foreign-Trade Zone (FTZ) 46; Authorization of Production Activity; Patheon Pharmaceuticals Inc.; (Pharmaceutical Products); Cincinnati, Ohio, 3635 [2024-00983]

Download as PDF Federal Register / Vol. 89, No. 13 / Friday, January 19, 2024 / Notices collections and therefore not subject to the PRA. Cynthia Long, Administrator, Food and Nutrition Service. [FR Doc. 2024–00997 Filed 1–18–24; 8:45 am] BILLING CODE 3410–30–P DEPARTMENT OF COMMERCE Census Bureau ddrumheller on DSK120RN23PROD with NOTICES1 Agency Information Collection Activities; Submission to the Office of Management and Budget (OMB) for Review and Approval; Comment Request; Census Household Panel Topical 4, Topical 5, and Topical 6 Operations On December 8, 2023, the Department of Commerce received clearance from the Office of Management and Budget (OMB) in accordance with the Paperwork Reduction Act of 1995 to conduct the second and third Census Household Panel topical operations (OMB No. 0607–1025, Exp. 6/20/26). The Census Household Panel is designed to ensure availability of frequent data collection for nationwide estimates on a variety of topics for a variety of subgroups of the population. This notice serves to inform of the Department’s intent to request clearance from OMB to conduct topical operations 4, 5, and 6. Topical surveys 4 and 5 will include content from Pew’s National Public Opinion Reference Survey and the National Center for Health Statistics’ Research and Development Survey. These are being asked for methodological reasons to study the representativeness of the originally recruited panel members along different benchmarked dimensions. Additionally, in Topical 4, we ask some questions about improving the CHP respondent experience. In Topical survey 6, we are incorporating a self-administered version of the Survey of Income and Program Participation (SIPP) roster and demographic questions into the Census Household Panel to test their usability in the field. The Department of Commerce will submit the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995, on or after the date of publication of this notice. We invite the general public and other Federal agencies to comment on proposed, and continuing information collections, which helps us assess the impact of our information collection VerDate Sep<11>2014 18:42 Jan 18, 2024 Jkt 262001 requirements and minimize the public’s reporting burden. Public comments were previously requested via the Federal Register on February 6, 2023, during a 60-day comment period. This notice allows for an additional 30 days for public comments. Agency: U.S. Census Bureau, Commerce. Title: Census Household Panel Topical 4, Topical 5, and Topical 6 Operations. OMB Control Number: 0607–1025. Form Number(s): Not yet determined. Type of Request: Request for a Revision of a Currently Approved Collection. Number of Respondents: 11,000 panel members. Average Hours per Response: 4 hours per year (20 minutes for monthly collection). Burden Hours: 43,956. Needs and Uses: The Census Household Panel is a probability-based nationwide nationally representative survey panel designed to test the methods to collect data on a variety of topics of interest, and for conducting experimentation on alternative question wording and methodological approaches. The goal of the Census Household Panel is to ensure availability of frequent data collection for nationwide estimates on a variety of topics and a variety of subgroups of the population, meeting standards for transparent quality reporting of the Federal Statistical Agencies and the Office of Management and Budget (OMB). Panelists and households selected for the Panel were recruited from the Census Bureau’s gold standard Master Address File. This ensures the Panel is rooted in this rigorously developed and maintained frame and available for linkage to administrative records securely maintained and curated by the Census Bureau. Invitations to complete the monthly surveys will be sent via email and SMS messages, and for experimental purposes, Topical 4 invitations will include pressure-sealed post-cards. Questionnaires will be mainly internet self-response. The Panel will maintain representativeness by allowing respondents who do not use the internet to respond via computerassisted telephone interviewing (CATI). All panelists will receive an incentive for each complete questionnaire. Periodic replenishment samples will maintain representativeness and panelists will be replaced after a period of three years. Affected Public: Individuals or Households. Frequency: Monthly. PO 00000 Frm 00005 Fmt 4703 Sfmt 9990 3635 Respondent’s Obligation: Voluntary. Legal Authority: Title 13, United States Code, Sections 141,182 and 193. This information collection request may be viewed at www.reginfo.gov. Follow the instructions to view the Department of Commerce collections currently under review by OMB. Written comments and recommendations for the proposed information collection should be submitted within 30 days of the publication of this notice on the following website www.reginfo.gov/ public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function and entering either the title of the collection or the OMB Control Number 0607–1025. Sheleen Dumas, Department PRA Clearance Officer, Office of the Under Secretary for Economic Affairs, Commerce Department. [FR Doc. 2024–01034 Filed 1–18–24; 8:45 am] BILLING CODE 3510–07–P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–52–2023] Foreign-Trade Zone (FTZ) 46; Authorization of Production Activity; Patheon Pharmaceuticals Inc.; (Pharmaceutical Products); Cincinnati, Ohio On September 18, 2023, Patheon Pharmaceuticals Inc. submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 46K, in Cincinnati, Ohio. The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (88 FR 67230–67231, September 29, 2023). On January 16, 2024, the applicant was notified of the FTZ Board’s decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board’s regulations, including section 400.14. Dated: January 16, 2024. Elizabeth Whiteman, Executive Secretary. [FR Doc. 2024–00983 Filed 1–18–24; 8:45 am] BILLING CODE 3510–DS–P E:\FR\FM\19JAN1.SGM 19JAN1

Agencies

[Federal Register Volume 89, Number 13 (Friday, January 19, 2024)]
[Notices]
[Page 3635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00983]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-52-2023]


Foreign-Trade Zone (FTZ) 46; Authorization of Production 
Activity; Patheon Pharmaceuticals Inc.; (Pharmaceutical Products); 
Cincinnati, Ohio

    On September 18, 2023, Patheon Pharmaceuticals Inc. submitted a 
notification of proposed production activity to the FTZ Board for its 
facility within Subzone 46K, in Cincinnati, Ohio.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (88 FR 67230-67231, September 29, 
2023). On January 16, 2024, the applicant was notified of the FTZ 
Board's decision that no further review of the activity is warranted at 
this time. The production activity described in the notification was 
authorized, subject to the FTZ Act and the FTZ Board's regulations, 
including section 400.14.

    Dated: January 16, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-00983 Filed 1-18-24; 8:45 am]
BILLING CODE 3510-DS-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.